Universal Health Services Inc. (UHS): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Universal Health Services ( UHS) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.4%. By the end of trading, Universal Health Services rose $0.90 (1.3%) to $71.87 on average volume. Throughout the day, 646,849 shares of Universal Health Services exchanged hands as compared to its average daily volume of 719,800 shares. The stock ranged in a price between $70.94-$72.74 after having opened the day at $70.94 as compared to the previous trading day's close of $70.97. Other companies within the Health Services industry that increased today were: Amedisys ( AMED), up 22.4%, Air Methods ( AIRM), up 16.9%, Gentiva Health Services ( GTIV), up 15.8% and Uroplasty ( UPI), up 12.8%.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services has a market cap of $6.4 billion and is part of the health care sector. Shares are up 46.8% year to date as of the close of trading on Thursday. Currently there are 11 analysts that rate Universal Health Services a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Universal Health Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the negative front, Pingtan Marine Enterprise ( PME), down 82.2%, Biolase ( BIOL), down 22.7%, AxoGen ( AXGN), down 22.6% and BG Medicine ( BGMD), down 13.4%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

Flu Season May Make Hospital Cash Registers Feel Better ... but Maybe Not

Big Opportunities to Buy Stocks Have Secretly Emerged

Big Opportunities to Buy Stocks Have Secretly Emerged

The Real Story Is Not Tax Reform; It Is Global Demand: Market Recon
The Activist Who Pushed Whole Foods Into the Arms of Amazon Could Target These Companies Next